Your browser doesn't support javascript.
loading
Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy.
Bowyer, S; Prithviraj, P; Lorigan, P; Larkin, J; McArthur, G; Atkinson, V; Millward, M; Khou, M; Diem, S; Ramanujam, S; Kong, B; Liniker, E; Guminski, A; Parente, P; Andrews, M C; Parakh, S; Cebon, J; Long, G V; Carlino, M S; Klein, O.
Afiliação
  • Bowyer S; Rockingham General Hospital, Cooloongup, Western Australia, Australia.
  • Prithviraj P; School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia.
  • Lorigan P; Olivia Newton- John Cancer Centre, Austin Hospital, Heidelberg, Melbourne, Victoria, Australia.
  • Larkin J; Olivia Newton-John Cancer Research Institute, Heidelberg, Melbourne, Victoria, Australia.
  • McArthur G; The Christie NHS Foundation Trust and University of Manchester, Manchester, UK.
  • Atkinson V; Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Millward M; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Khou M; Princess Alexandra Hospital, Greenslopes Private Hospital, Brisbane, Queensland, Australia.
  • Diem S; School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia, Australia.
  • Ramanujam S; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
  • Kong B; Westmead Hospital, Sydney, New South Wales, Australia.
  • Liniker E; Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Guminski A; Melanoma Institute Australia, Sydney, New South Wales, Australia.
  • Parente P; Westmead Hospital, Sydney, New South Wales, Australia.
  • Andrews MC; Melanoma Institute Australia, Sydney, New South Wales, Australia.
  • Parakh S; Melanoma Institute Australia, Sydney, New South Wales, Australia.
  • Cebon J; Box Hill Hospital, Box Hill, Victoria, Australia.
  • Long GV; Olivia Newton- John Cancer Centre, Austin Hospital, Heidelberg, Melbourne, Victoria, Australia.
  • Carlino MS; Olivia Newton-John Cancer Research Institute, Heidelberg, Melbourne, Victoria, Australia.
  • Klein O; Olivia Newton- John Cancer Centre, Austin Hospital, Heidelberg, Melbourne, Victoria, Australia.
Br J Cancer ; 114(10): 1084-9, 2016 05 10.
Article em En | MEDLINE | ID: mdl-27124339
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article